Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2023 > Aqilion inks research collaboration with Merck to discover, develop and commercialize small molecule inhibitors

Aqilion inks research collaboration with Merck to discover, develop and commercialize small molecule inhibitors

Aqilion inks research collaboration with Merck to discover, develop and commercialize small molecule inhibitors

Read also

Pharma Tariffs
Pharma Tariffs
Pharma Tariffs Back In Spotlight On New Trump Threat
FDA approves Lilly’s Inluriyo
FDA approves Lilly’s Inluriyo
FDA approves Lilly’s Inluriyo to treat advanced breast cancer
Synaffix and Qurient
Synaffix and Qurient
Synaffix and Qurient enter licensing deal for dual-payload ADC
Biotech Stocks Facing
Biotech Stocks Facing
Biotech Stocks Facing FDA Decision In October 2025
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand